Gene Therapy Market in China

USD 10

SKU: DH10258C Categories: ,
Get complete access to all DataPass statistics. Plans are available for as low as $200 per month.

Summary

The gene therapy market in China is poised to grow by US$ 18,731 million from 2021 to 2027, registering a CAGR of 22.8% during the forecast period, according to StrategyHelix.

This 2nd edition of Gene Therapy Market in China includes following information:
Market Overview: Market Size, Grow Rate, CAGR
Type: Rare Disease, Oncology
Years Considered: this database covers the period 2022-2027


Order Processing

After you have placed your order and your payment has been authorized, the database download link will be emailed to you instantly. Please note that the database is supplied in an Excel spreadsheet.

StrategyHelix’ data is protected by copyright and cannot be supplied to any third party.


About DataPass

StrategyHelix DataPass produces a series of directories and databases on industries, economies and consumers in Western and Central Europe, North and South America, Asia Pacific, the Middle East and Africa. DataPass aims at helping our clients analyze market context and identify future trends.


Product Type

Database

Release Date

30 March 2022

Region

Asia Pacific

Release Year

2022

StrategyHelix Black LOGO

REQUEST SAMPLE

Please fill out our form and we will get back to you.

Gene Therapy Market in China

login